Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nature Cell Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncb899PMID 12510195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in Brief Cloning and Characterization of a Mouse Gene with Homology to the Human von Hippel-. Lindau Disease Tumor Suppressor Gene : Implications for the Potential Organization of the Human von Hippel-Lindau Disease Gene

  2006cited by this paper
• Recurrent polytopic chromaffin paragangliomas in a 9-year-old boy resulting from a novel germline mutation in the von Hippel-Lindau gene.

  2002cited by this paper
• Oxygen-Dependent Ubiquitination and Degradation of Hypoxia-Inducible Factor Requires Nuclear-Cytoplasmic Trafficking of the von Hippel-Lindau Tumor Suppressor Protein

  2002cited by this paper
• Molecular basis of the VHL hereditary cancer syndrome

  2002cited by this paper
• Endoplasmic reticulum/cytosolic localization of von Hippel‐Lindau gene products is mediated by a 64–amino acid region

  2001cited by this paper
• Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.

  2001cited by this paper
• von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.

  2001cited by this paper
• VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.

  2000cited by this paper
• The von Hippel-Lindau tumor suppressor targets to mitochondria.

  2000cited by this paper
• Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein

  2000cited by this paper
• Ran-mediated Nuclear Export of the von Hippel-Lindau Tumor Suppressor Protein Occurs Independently of Its Assembly with Cullin-2*

  2000cited by this paper
• Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex.

  2000cited by this paper
• Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein*

  2000cited by this paper
• The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

  1999cited by this paper
• Transcription-Dependent Nuclear-Cytoplasmic Trafficking Is Required for the Function of the von Hippel-Lindau Tumor Suppressor Protein

  1999cited by this paper
• The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity.

  1999cited by this paper
• Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene.

  1999cited by this paper
• Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity

  1999cited by this paper
• The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.

  1998cited by this paper
• pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation.

  1998cited by this paper
• A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.

  1998cited by this paper
• Software and database for the analysis of mutations in the VHL gene

  1998cited by this paper
• Association of human CUL‐1 and ubiquitin‐conjugating enzyme CDC34 with the F‐box protein p45SKP2: evidence for evolutionary conservation in the subunit composition of the CDC34–SCF pathway

  1998cited by this paper
• Subcellular localization of the von Hippel‐Lindau disease gene product is cell cycle‐dependent

  1998cited by this paper
• The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.

  1997cited by this paper
• Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues.

  1997cited by this paper
• Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density.

  1996cited by this paper
• Expression pattern of the von Hippel-Lindau protein in human tissues.

  1996cited by this paper
• Germline mutations in the Von Hippel‐Lindau disease (VHL) gene in families from North America, Europe, and Japan

  1996cited by this paper
• Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.

  1996cited by this paper
• Tumour suppression by the human von Hippel-Lindau gene product

  1995cited by this paper
• Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.

  1995cited by this paper
• Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

  1995cited by this paper
• Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect

  1995cited by this paper
• Germline mutations in the von Hippel–Lindau disease tumor suppressor gene: Correlations with phenotype

  1995cited by this paper
• Mutations of the VHL tumour suppressor gene in renal carcinoma

  1994cited by this paper
• Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.

  1994cited by this paper
• Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates.

  1991cited by this paper

• 5′ UTR length regulates alternative N-terminal protein isoform production in health and disease

  2026cites this paper
• Omics-Based Characterization of BTB Gene Family in T. aestivum, Reveals the Potential of TaBTB11/56/57/58 in Combined Heat and Drought Stress Regulation

  2025cites this paper
• Primary cilia in cancer: structures, functions, mechanisms, and therapeutic implications

  2025cites this paper
• Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma

  2025cites this paper
• Microtubule dynamics is a therapeutic vulnerability in VHL-deficient renal cell carcinoma

  2025cites this paper
• HIF-1α and HIF-2α transcription factors differentially regulate lung alveolar macrophage function

  2025cites this paper
• Von Hippel-Lindau syndrome: clinical features, genetic foundations, and management strategies

  2025cites this paper
• Maladie de von Hippel-Lindau

  2025cites this paper
• Oncogenic Cell Tagging and Single-Cell Transcriptomics Reveal Cell Type–Specific and Time-Resolved Responses to Vhl Inactivation in the Kidney

  2024cites this paper
• Influence of Hypoxia on the Airway Epithelium.

  2024cites this paper
• SOCS domain targets ECM assembly in lung fibroblasts and experimental lung fibrosis

  2024cites this paper
• SOCS domain targets ECM assembly in lung fibroblasts and experimental lung fibrosis

  2024cites this paper
• Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma.

  2024cites this paper
• Loss of SETD2 in wild‐type VHL clear cell renal cell carcinoma sensitizes cells to STF‐62247 and leads to DNA damage, cell cycle arrest, and cell death characteristic of pyroptosis

  2024cites this paper
• Primary cilia and actin regulatory pathways in renal ciliopathies

  2024cites this paper
• Primary cilia as antennas for oxygen.

  2024cites this paper
• Ciliated, Mitochondria-Rich Postmitotic Cells are Immune-privileged, and Mimic Immunosuppressive Microenvironment of Tumor-Initiating Stem Cells: From Molecular Anatomy to Molecular Pathway.

  2023cites this paper
• VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in Clear Cell Renal Cell Carcinoma

  2023cites this paper
• Evolution of the HIF targeted therapy in clear cell renal cell carcinoma.

  2023cites this paper
• Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata

  2022cites this paper
• VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions

  2022cites this paper
• The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis

  2022influential citation
• ENKD1 promotes epidermal stratification by regulating spindle orientation in basal keratinocytes

  2022cites this paper
• VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma

  2022cites this paper
• The Functional Hallmarks of Cancer Predisposition Genes

  2021cites this paper
• pVHL promotes lysosomal degradation of YAP in lung adenocarcinoma.

  2021cites this paper
• Hsp90 chaperone code and the tumor suppressor VHL cooperatively regulate the mitotic checkpoint

  2021cites this paper
• Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening

  2021cites this paper
• CMAR_A_311548 4351..4357

  2021cites this paper
• Von Hippel–Lindau tumor suppressor (VHL) stimulates TOR signaling by interacting with phosphoinositide 3-kinase (PI3K)

  2020cites this paper
• The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer.

  2020cites this paper
• The long form of pVHL is artifactually modified by serine protease inhibitor AEBSF

  2020cites this paper
• Kv10.1 Regulates Microtubule Dynamics during Mitosis

  2020cites this paper
• From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer.

  2020cites this paper
• Interaction with p53 explains a pro-proliferative function for VHL in cancer

  2020cites this paper
• Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

  2020cites this paper
• Title Low VHL mRNA Expression is Associated with More Aggressive TumorFeatures of Papillary Thyroid Carcinoma

  2019cites this paper
• VHL Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 Screens

  2019cites this paper
• Ubiquitination of MAP1LC3B by pVHL is associated with autophagy and cell death in renal cell carcinoma

  2019cites this paper
• Arginine refolds, stabilizes, and restores function of mutant pVHL proteins in animal model of the VHL cancer syndrome

  2018cites this paper
• The von Hippel-Lindau Gene Is Required to Maintain Renal Proximal Tubule and Glomerulus Integrity in Zebrafish Larvae

  2018cites this paper
• The HIF and other quandaries in VHL disease

  2018cites this paper
• Adenoviral delivery of VHL suppresses bone sarcoma cell growth through inhibition of Wnt/β-catenin signaling

  2018cites this paper
• Cystic Kidney Diseases Associated with Increased Cancer Risk: Tuberous Sclerosis Complex, Von Hippel-Lindau, and Birt-Hogg-Dubé

  2018cites this paper
• Metastatic Renal Cell Cancer—Systemic Therapy

  2018cites this paper
• Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma

  2018cites this paper
• Mixed signals from the cell's antennae: primary cilia in cancer

  2018cites this paper
• Role of Hypoxia Inducible Factors in Alveolar Macrophage Physiology

  2018cites this paper
• Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications

  2017cites this paper
• Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation

  2017cites this paper
• A Patent Review on Thiazole Derivatives (2008-2013)

  2017cites this paper
• The Emerging Genetic Landscape in Renal Cell Carcinoma

  2017cites this paper
• HIF-dependent Signaling Pathways in Cancer

  2017cites this paper
• Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control

  2017influential citation
• VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2

  2017cites this paper
• Cell Division Machinery and Disease

  2017cites this paper
• The Elephant in the Room: The Role of Microtubules in Cancer.

  2017cites this paper
• Structure of the MOB1-NDR2 complex

  2017cites this paper
• Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL

  2017cites this paper
• Role of primary cilia in non-dividing and post-mitotic cells

  2017cites this paper
• Nuclear import mechanism of neurofibromin for localization on the spindle and function in chromosome congression

  2016cites this paper
• Identification and characterization of interactions between bacterial WxxxE-virulence proteins and host cell proteins

  2016cites this paper
• Protéine-kinases et cancer du rein : Découverte et validation d’une nouvelle combinaison d’inhibiteurs ciblant les protéine-kinases ATM et CK2

  2016cites this paper
• jSplice: a high-performance method for accurate prediction of alternative splicing events and its application to large-scale renal cancer transcriptome data

  2016cites this paper
• ASB7 regulates spindle dynamics and genome integrity by targeting DDA3 for proteasomal degradation

  2016cites this paper
• Primary cilia: a link between hormone signalling and endocrine-related cancers?

  2016cites this paper
• Neurological Management of Von Hippel-Lindau Disease

  2016cites this paper
• HIF Stabilization Weakens Primary Cilia

  2016cites this paper
• Forkhead Transcription Factor 3a (FOXO3a) Modulates Hypoxia Signaling via Up-regulation of the von Hippel-Lindau Gene (VHL)*

  2016cites this paper
• Non-canonical GLI1/2 activation by PI3K/AKT signaling in renal cell carcinoma: A novel potential therapeutic target.

  2016cites this paper
• Correction for Delgehyr et al., Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability

  2016influential citation
• Expression of Nucleolin Affects Microtubule Dynamics

  2016cites this paper
• USP9X destabilizes pVHL and promotes cell proliferation

  2016cites this paper
• The VHL short variant involves in protein quality control.

  2016cites this paper
• VHL and HIF in Clear Cell Renal Cell Carcinoma: Molecular Abnormalities and Potential Clinical Applications

  2015cites this paper
• Combined Deletion of Vhl and Kif3a Accelerates Renal Cyst Formation.

  2015cites this paper
• Sporadic RCC: Abnormalities in Histone-Modifying Genes

  2015cites this paper
• Destruction of a distal hypoxia response element abolishes trans-activation of the PAG1 gene mediated by HIF-independent chromatin looping

  2015cites this paper
• Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity.

  2015cites this paper
• Renal Cell Carcinoma with Rhabdoid Features: Report of a Rare Case Diagnosed on Endobronchial Ultrasound-Guided Fine Needle Aspiration

  2015cites this paper
• Genotype–phenotype analysis of von Hippel–Lindau syndrome in fifteen Indian families

  2015cites this paper
• Actin Cytoskeletal Organization in Drosophila Germline Ring Canals Depends on Kelch Function in a Cullin-RING E3 Ligase

  2015cites this paper
• Management of serous cystic neoplasms of the pancreas

  2015cites this paper
• Role of Ran-regulated nuclear-cytoplasmic trafficking of pVHL in the regulation of microtubular stability-mediated HIF-1α in hypoxic cardiomyocytes

  2015cites this paper
• Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy.

  2015cites this paper
• A clearer view of the molecular complexity of clear cell renal cell carcinoma.

  2015cites this paper
• Small Molecules Targeting the VHL/Hypoxic Phenotype

  2014cites this paper
• Constitutively active NDR1-PIF kinase functions independent of MST1 and hMOB1 signalling.

  2014cites this paper
• Tumor suppressor NF2/Merlin is a microtubule stabilizer.

  2014cites this paper
• BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling

  2014cites this paper
• Interaction between Nm23 and the tumor suppressor VHL

  2014cites this paper
• Computational and Experimental Characterization of dVHL Establish a Drosophila Model of VHL Syndrome

  2014cites this paper
• The multifaceted von Hippel–Lindau tumour suppressor protein

  2014cites this paper
• Suppression of Tumor Development for Fibronectin Matrix Assembly and pVHL Modification by NEDD8 Is Required

  2014cites this paper
• pVHL acts as a downstream target of E2F1 to suppress E2F1 activity.

  2014cites this paper
• The von hippel-lindau protein suppresses androgen receptor activity.

  2014cites this paper
• Low VHL mRNA Expression is Associated with More Aggressive Tumor Features of Papillary Thyroid Carcinoma

  2014cites this paper
• VHL, the story of a tumour suppressor gene

  2014cites this paper
• PROMOTE LIBERATION OF MITOTIC STRESS-INDUCED DEATH

  2014cites this paper
• The role of the cilium in hereditary tumor predisposition syndromes

  2014cites this paper